Timeline
Last
$74.40
-1.64 (-2.16%)
24HR-2.2%
1W-4.5%
1M-1.4%
1Y-49.1%
Valuation
- Market Cap
- —
- Enterprise Value
- $39.6B
- P/E (TTM)
- 12.20x
- Forward P/E
- 10.07x
- Price / Sales
- —
- EV / EBITDA
- 9.73x
Cash Flow
- Operating Cash Flow
- $2.8B
- Free Cash Flow
- $1.8B
- FCF Margin
- 18.7%
- Cash Conversion
- 63.8%
- Cash / Share
- $4.6
Margins & Growth
- Gross Margin
- 71.8%
- Operating Margin
- 36.6%
- EBITDA Margin
- 42.7%
- Net Margin
- 28.0%
- Revenue Growth
- 2.9%
- Earnings Growth
- 6.0%
Balance Sheet
- Total Cash
- $1.9B
- Total Debt
- $9.3B
- Net Cash
- -$7.3B
- Debt / Equity
- 2.86x
- Current Ratio
- 3.15x
- Quick Ratio
- 1.68x
Returns & Ownership
- Return on Assets
- 15.5%
- Return on Equity
- 67.7%
- Dividend Yield
- 2.7%
- Payout Ratio
- 33.3%
- Beta
- 0.73
- Institutional Ownership
- 101.5%
Latest EPS$1.53-0.1% surprise
Beat rate75%4 prints
Avg surprise+0.0%vs consensus
Next printAug 6, 2026EPS $1.85
Quarterly EPS vs consensus
4 quarters Actual ConsensusLabels: beat $ · YoY %Revisions 2 up / 13 down
Earnings transcripts
Read management commentary and analyst Q&A.
No transcript dates are available yet for this ticker.
Forward estimates
Consensus expectations and estimate momentum.
PeriodEPSRevenueGrowth
0QJun 2026
$1.85$2.5B+5.3%+1QSep 2026
$1.85$2.5B+8.7%0YDec 2026
$6.87$9.7B+7.1%+1YDec 2027
$7.39$10.1B+7.6%Primary research
Recent company filings
Jump directly to earnings releases, quarterly reports, and material updates.
8-KCorporate Changes & Voting Matters2026-05-228-KCorporate Changes & Voting Matters2026-05-208-KCorporate Changes & Voting Matters2026-05-078-KCorporate Changes & Voting Matters2026-02-128-KCorporate Changes & Voting Matters2026-02-058-KCorporate Changes & Voting Matters2025-12-188-KCorporate Changes & Voting Matters2025-12-118-KCorporate Changes & Voting Matters2025-12-028-KCorporate Changes & Voting Matters2025-11-048-KCorporate Changes & Voting Matters2025-10-288-KCorporate Changes & Voting Matters2025-10-098-KCorporate Changes & Voting Matters2025-08-27
ZTS stock research · Zoetis Inc.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livest…
| Last price | $74.4 |
|---|---|
| Day change | -1.64 (-2.16%) |
| Market cap | — |
| P/E (TTM) | 12.20x |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |